- Home
- VIR vs ASA Comparison
VIR vs ASA Comparison
Compare VIR & ASA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIR
- ASA
- Stock Information
- Founded
- VIR 2016
- ASA 1958
- Country
- VIR United States
- ASA United States
- Employees
- VIR N/A
- ASA N/A
- Industry
- VIR Biotechnology: Pharmaceutical Preparations
- ASA Precious Metals
- Sector
- VIR Health Care
- ASA Industrials
- Exchange
- VIR Nasdaq
- ASA Nasdaq
- Market Cap
- VIR 706.4M
- ASA 585.6M
- IPO Year
- VIR 2019
- ASA N/A
- Fundamental
- Price
- VIR $4.38
- ASA $35.06
- Analyst Decision
- VIR Strong Buy
- ASA
- Analyst Count
- VIR 8
- ASA 0
- Target Price
- VIR $30.25
- ASA N/A
- AVG Volume (30 Days)
- VIR 1.0M
- ASA 119.3K
- Earning Date
- VIR 08-06-2025
- ASA 09-02-2025
- Dividend Yield
- VIR N/A
- ASA 0.17%
- EPS Growth
- VIR N/A
- ASA 331.75
- EPS
- VIR N/A
- ASA 14.01
- Revenue
- VIR $19,000,000.00
- ASA $3,923,667.00
- Revenue This Year
- VIR N/A
- ASA N/A
- Revenue Next Year
- VIR $0.56
- ASA N/A
- P/E Ratio
- VIR N/A
- ASA $2.44
- Revenue Growth
- VIR N/A
- ASA 66.52
- 52 Week Low
- VIR $4.16
- ASA $18.51
- 52 Week High
- VIR $14.45
- ASA $35.60
- Technical
- Relative Strength Index (RSI)
- VIR 35.16
- ASA 60.41
- Support Level
- VIR $4.33
- ASA $33.90
- Resistance Level
- VIR $4.57
- ASA $35.57
- Average True Range (ATR)
- VIR 0.22
- ASA 0.99
- MACD
- VIR -0.02
- ASA 0.04
- Stochastic Oscillator
- VIR 21.53
- ASA 86.93
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.
About ASA ASA Gold and Precious Metals Limited
ASA Gold And Precious Metals Ltd is a closed-end, non-diversified investment company. Its objective is to provide long-term capital appreciation through investing in companies engaged in the exploration for, development of projects, or mining of precious metals and minerals.